Back to search

Article

Prioritizing Parkinson’s disease risk genes in genome-wide association loci

2024-12-14

Abstract excerpt

Recent advancements in Parkinson’s disease (PD) drug development have been significantly driven by genetic research. Importantly, drugs supported by genetic evidence are more likely to be approved. While genome-wide association studies (GWAS) are a powerful tool to nominate genomic regions associated with certain traits or diseases, pinpointing the causal biologically relevant gene is often challenging. Our aim wa...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
01be91e8-7936-5524-bf4e-bf2488d6211e
DOI
10.1101/2024.12.13.24318996
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Prioritizing Parkinson’s disease risk genes in genome-wide association lociDOI 10.1101/2024.12.13.24318996
Select a neighboring publication to make it the new centre.